Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating subcutaneous amlitelimab monotherapy versus placebo in participants aged 12 years and older with moderate-to-severe…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
A Phase 3 clinical trial evaluating rocatinlimab in combination with topical corticosteroids and/or topical calcineurin inhibitors for adult…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort [NA]
A clinical trial comparing broadband versus narrowband phototherapy for eczema (atopic dermatitis) within the CACTI cohort has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis [Phase 1]
A Phase 1 study to assess safety, tolerability, and pharmacokinetics of ATTO-3712 in healthy volunteers and subjects with atopic dermatitis;…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Allergic Disease Onset Prevention Study [Phase 1, Phase 2]
Siolta Therapeutics reports completion of Phase 1 and Phase 2 for the Allergic Disease Onset Prevention Study, investigating prevention stra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: NiPPeR Randomised Trial - Child Follow Up Study [NA]
The NiPPeR randomized trial child follow-up study has completed, evaluating the impact of early-life nutrition on obesity, metabolic and gro…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults [Phase 1]
A Phase 1 pharmacokinetic study to assess how different forms of PF 08049820 are absorbed into the bloodstream in healthy adults, with Atopi…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. [Phase 2]
A Phase 2 long-term study (AtDvance) evaluating GSK1070806 for atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 dose-finding trial of the investigational drug GSK1070806 in adults with moderate-to-severe atopic dermatitis has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis [Phase 4]
Phase 4 trial update presents immunogenetic profiling data for dupilumab in atopic dermatitis. Results of the biomarker analyses have been p…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) [Phase 1, Phase 2]
A Phase 1/2 study evaluating IMG-007 in adults with atopic dermatitis was terminated, with results posted for safety, pharmacokinetics, and …
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) [Phase 3]
Amgen completed a Phase 3 trial (ROCKET-VOYAGER) evaluating rocatinlimab’s impact on vaccine antibody response in patients with moderate-to-…
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Opzelura (ruxolitinib) cream in adults with moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) [Phase 1, Phase 2]
This clinical trial update reports the completion of a combined single-ascending-dose (Part A) and repeat-dose (Part B) study of UCB1381 to …
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 proof-of-concept study evaluating BSI-045B for moderate-to-severe atopic dermatitis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]
This Phase 1 study of LY3872386 in healthy participants and individuals with atopic dermatitis was terminated, and results have been posted …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis [Phase 3]
Phase 3 trial of CM310 injection in adolescents with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of CM310 in Adolescent Subjects With Atopic Dermatis [Phase 3]
A Phase 3 clinical trial evaluating CM310 for adolescent atopic dermatitis is currently ACTIVE_NOT_RECRUITING, indicating the study is ongoi…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of LW402 in Moderate-to-Severe Atopic Dermatitis [Phase 2]
Clinical trial update announcing completion of a Phase 2 study of LW402 for moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A clinical trial evaluating Abrocitinib in adults with moderate to severe atopic dermatitis has been terminated, and the results have been p…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin
This document reports the completion of a trial assessing the tolerance and efficacy of a sunscreen product used in real-world conditions in…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients [Phase 3]
This document reports the completion of a Phase 3 trial comparing methotrexate and cyclosporine in patients with moderate-to-severe atopic d…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic Dermatitis
Completed clinical trial evaluating in-use tolerance of sunscreen under dermatological and pediatric controls in children with atopic dermat…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis [Phase 1]
Phase 1 clinical trial update showing CM512 was studied in healthy subjects and patients with Atopic Dermatitis, and the study status is com…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic d…